By Benjamin Horney ( December 9, 2016, 5:25 PM EST) -- Drug research firm Pharmaceutical Products Development LLC is mulling a sale that could value the company at about $5 billion, according to a Friday report from Dow Jones. According to the report, PPD has tapped Goldman Sachs Group Inc., JPMorgan Chase & Co. and Centerview Partners to advise as it seeks out a buyer, and prospective bidders could be identified as soon as this month. A deal could be inked in the first quarter of 2017, the report noted. PPD is owned by the Carlyle Group and Hellman & Friedman LLC....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.